Skip to content
thispeptide

Does Sermorelin Work? What the Human Studies Measured

Small studies in older men show sermorelin raises growth hormone, and at twice-daily doses IGF-1. No placebo-controlled trial has shown it changes muscle, fat or sleep in adults.

Article type
Evidence
Evidence on Sermorelin for sleep
Small studies2 controlled human studies cited here for sleep, none reporting its size in the abstract.
Sources
6
Reading
6 min
By Craig PalmerPublished
SermorelinGHRH(1-29)PituitaryGHRH receptorGH pulsesmeasuredIGF-1mixedBody composition and sleep: no placebo trial of sermorelin

Sermorelin is sold by telehealth clinics as a gentler way to raise growth hormone, and the question most people type is simply whether it works. The honest answer depends on which effect you mean, because the studies in people measured the hormone far more often than they measured anything you would notice.

This article walks through the human studies behind the sermorelin guide, from the hormone response to the questions readers bring from the sleep and recovery goals, and marks the point where each one stops.

What sermorelin is, and why it can be prescribed

Sermorelin is GHRH(1-29), the first 29 amino acids of the hormone the hypothalamus uses to tell the pituitary to release growth hormone. It was once approved as GEREF for children whose own growth hormone was deficient.

GEREF left the market, but the FDA determined in 2013 that it was not withdrawn for reasons of safety or effectiveness, which is what allows pharmacies to compound sermorelin now, for adults and for uses the approval never covered.

What happened to growth hormone and IGF-1

The clearest human result is the one closest to the mechanism: in older men, sermorelin raises growth hormone. In a two-week study of 10 healthy men with a mean age of 68, 1 mg injected twice daily raised 24-hour growth hormone and IGF-1 to the levels of a group of young men. The 0.5 mg dose produced no significant change [2].

Dose and timing mattered in the other direction too. When 11 men aged 64 to 76 injected 2 mg once nightly for six weeks, nighttime growth hormone rose (P < .02), but IGF-1 did not move. The authors concluded that single nightly doses are less effective than several doses a day [1].

That matters for a patient because IGF-1 is the signal most of growth hormone’s effects on tissue run through. A schedule that raises growth hormone without raising IGF-1 may change a number on a lab report and little else.

Did muscle, fat or strength change?

In the six-week nightly study, weight, body mass index, muscle and fat measured by DEXA scan, blood sugar and lipids were all unchanged. Two of six strength measures and one endurance test improved, in a study with no placebo group to compare against [1].

A blinded study sometimes cited for body-composition benefits used a different molecule, a modified analog called [Nle27]GHRH(1-29), in 19 men and women aged 55 to 71. Lean mass rose in men only, and women showed no change in lean mass or insulin sensitivity. IGF-1 drifted back toward baseline by the sixteenth week, and the placebo month came first for everyone rather than running alongside the drug [3].

The one large study of sermorelin itself is in children with growth hormone deficiency, the use GEREF was approved for. Among 110 enrolled children, height velocity rose from 4.1 to 8.0 cm a year after six months, in a trial with no control group [4].

The sleep question

Sermorelin is often sold for sleep, but the two controlled sleep studies of GHRH point in opposite directions, and neither used the nightly injection under the skin that sellers prescribe.

In healthy young men, an intravenous dose of GHRH given in early sleep did not change deep sleep, while the same dose given in the third REM period cut wakefulness and increased deep sleep almost tenfold [5]. In healthy young women, pulsed intravenous GHRH reduced REM or deep sleep compared with placebo, and the authors wrote that GHRH impairs sleep in women [6].

In the analog study of older adults, the one blinded study here that asked about sleep, sleep quality was unaffected in both men and women [3].

What no study has measured

No placebo-controlled trial of sermorelin has measured body composition, strength, recovery from training or sleep in adults. None of the studies here ran longer than about four months of active treatment, so long-term safety in healthy adults is simply not measured.

What this means if you are considering it

A prescriber can reasonably say that sermorelin raises growth hormone, and that twice-daily dosing raised IGF-1 in older men. A prescriber who promises better sleep, more muscle or less fat is describing a hope, not a result from these studies.

If you do go ahead, ask how your IGF-1 will be checked, since that is the measure the studies show can fail to move. Two of the sellers reviewed here, Strut Health and CoreAge Rx, list sermorelin, and each review says what the seller claims about it and what it cites.

Frequently asked questions

Does sermorelin raise IGF-1?
In 10 older men, 1 mg twice daily for two weeks raised IGF-1 significantly; the 0.5 mg dose did not. A single nightly 2 mg dose for six weeks raised growth hormone but did not change IGF-1.
What are the benefits of sermorelin?
The measured benefit in adults is a rise in growth hormone, and at twice-daily doses IGF-1. No placebo-controlled trial of sermorelin has shown changes in muscle, fat, strength or sleep in adults.

Sources

6 cited
  1. 1Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, et al. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. PMID 9005976
  2. 2Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR (1992). Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. PMID 1379256
  3. 3Khorram O, Laughlin GA, Yen SS (1997). Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. J Clin Endocrinol Metab. PMID 9141536
  4. 4Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, Landy H, Eengrand P, Shah S (1996). Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. J Clin Endocrinol Metab. PMID 8772599
  5. 5Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thorner MO, Copinschi G (1993). Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol. PMID 8476038
  6. 6Mathias S, Held K, Ising M, Weikel JC, Yassouridis A, Steiger A (2007). Systemic growth hormone-releasing hormone (GHRH) impairs sleep in healthy young women. Psychoneuroendocrinology. PMID 17850984

More on sleep